1588. Weight Change among People Living with HIV who switch from Oral Antiviral Therapy to Long Acting Injectable Cabotegravir/Rilpivirine in a University-Based Clinic

BACKGROUND: Integrase strand transfer inhibitors (INSTIs) are a key component of antiretroviral therapy (ART) for HIV treatment, but associated weight gain limits their use in some patients. This study measures weight in people living with HIV (PLWH) who switched to long-acting injectable (LAI) cabo...

Descripción completa

Detalles Bibliográficos
Autores principales: McNaboe, Lukas, Kostka, Julia, Ayala, Alvaro, Wakefield, Dorothy, Chirch, Lisa M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677389/
http://dx.doi.org/10.1093/ofid/ofad500.1423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677389/
http://dx.doi.org/10.1093/ofid/ofad500.1423

Ejemplares similares